Helen Heslop

36PUBLICATIONS
144CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Molecular targetsInnate immunityPsycholinguistics (incl. speech production and comprehension)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Jan 02, 2026
Autologous multiantigen-targeted T cell therapy for pancreatic cancer: a phase 1/2 trial.

Benjamin L Musher, Spyridoula Vasileiou, Brandon G Smaglo

|Feb 17, 2025
Long-term outcomes of GD2-directed CAR-T cell therapy in patients with neuroblastoma.

Che-Hsing Li, Sandhya Sharma, Andras A Heczey

|Feb 05, 2025
Differential antibody response to EBV proteome following EBVST immunotherapy in EBV-associated lymphomas.

Yomani D Sarathkumara, Nathan W Van Bibber, Zhiwei Liu

|Nov 28, 2024
Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers.

David Steffin, Nisha Ghatwai, Antonino Montalbano

|Jun 19, 2024
Time to optimize vaccination strategies in blood cancer patients.

Ibrahim N Muhsen, Helen E Heslop

|May 21, 2024
Phase I Trial of GD2.CART Cells Augmented With Constitutive Interleukin-7 Receptor for Treatment of High-Grade Pediatric CNS Tumors.

Frank Y Lin, Austin Stuckert, Candise Tat

Pageof 6

Frequent Collaborators

12 joint publications

Thao Wang

8 joint publications

Premal Lulla

7 joint publications

Carlos Ramos

5 joint publications

Andras Heczey